WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...
The addition of Foundayo® (orforglipron) gives Weight Watchers Med+ members a new FDA-approved oral GLP-1 option for weight lossNEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc.
A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and ...
WW International, Inc. (NASDAQ: WW) ("Weight Watchers"), the global leader in science-backed weight management, announced that it is now offering access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results